DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Emapunil
Emapunil
Présentation HJ
〔
WO 2015/072852 Al 21 May 2015 (21.05.2015) P O P C T
Stems for Nonproprietary Drug Names
Translocator Protein (TSPO): the New Story of the Old Protein in Neuroinflammation
WO 2015/072853 Al 21 May 2015 (21.05.2015) P O P C T
TSPO) Ligands and Benzodiazepines
Download Product Insert (PDF)
(12) United States Patent (10) Patent No.: US 8,158,152 B2 Palepu (45) Date of Patent: Apr
Research Article
Characterization of Tspo 18 Kda
The Agonistic TSPO Ligand XBD173 Attenuates the Glial Response
(12) United States Patent (10) Patent No.: US 8,980,887 B2 Yang Et Al
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
WHO Drug Information Vol. 18, No. 4, 2004
Translocator Protein 18 Ligand Emapunil Protects Against
8Th Annual Scientific Meeting
Anti-COVID-19 Compound Library (96-Well)
Top View
Exploiting the Indole Scaffold to Design Compounds Binding
Translocator Protein Ligand Protects Against Neurodegeneration in the MPTP Mouse Model of Parkinsonism
Characterization of Novel Mitochondrial Modulators for the Development of Neuroprotective Strategies Imane Lejri
Neurological Disease
XBD173 (AC-5216, Emapunil)
Antidepressant-Like and Anxiolytic-Like Effects of YL-IPA08, a Potent Ligand for the Translocator Protein (18 Kda)
Sleep Apnea and CMV Driver Safety
Positive Allosteric Modulation of GABAA Receptors in the Amygdala
Translocator Protein Ligand Protects Against Neurodegeneration in the MPTP Mouse Model of Parkinsonism
WO 2012/170676 Al 13 December 2012 (13.12.2012) P O P C T
(18 Kda) (TSPO) As a Therapeutic Target for Neurological and Psychiatric Disorders
(TSPO), in an Animal Model of Diabetes Mellitus
Diagnostic and Therapeutic Potential of TSPO Studies Regarding